Are antiepileptics really associated with suicidality?

January 2010
Reactions Weekly;1/9/2010 Part 1 of 2, Issue 1283, p6
The article discusses the highlights of studies on side effects of antiepileptic drugs (AEDs) presented at the 2009 meeting of the American Epilepsy Society (AES) in the U.S. A presentation during the meeting criticized an analysis which showed the risks of suicidal ideation and suicidal behavior for not including all antiepileptic drugs. Another paper showed that changes in the treatment using AES had no effects on suicidality.


Related Articles

  • Antiepileptics: suicidal behaviour.  // Reactions Weekly;2/28/2009, Issue 1241, p4 

    The article reports on a study conducted by the Netherlands Pharmacovigilance Centre (Lareb) on reports of suicidal ideation, suicidal attempt or suicide in patients receiving antiepileptic drugs. The study was conducted to determine whether the findings by the U.S. Food and Drug Administration...

  • Risk of suicidal ideation almost double with antiepileptics.  // Reactions Weekly;2/9/2008, Issue 1188, p1 

    The article discusses research on the risk of suicidal ideation on people taking antiepileptic drugs. It references a study by the U.S. Food and Drug Administration (FDA) published in the January 31, 2008 issue of "Internet Document." The FDA examined 199 placebo-controlled clinical studies...

  • Risk of suicidal behaviour in adults taking antidepressants. Geddes, John Richard; Barbui, Corrado; Cipriani, Andrea // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/22/2009, Vol. 339 Issue 7718, p411 

    The authors reflect on the risk of suicidal behavior associated with antidepressants utilization among adults. They claim that the use of antidepressants is coupled with warnings about the possibility of increased risk of suicidal ideation and behavior. They ponder on the reasons for the lack of...

  • MHRA receives further ADR reports with varenicline.  // Reactions Weekly;11/15/2008, Issue 1228, p3 

    The article focuses on the advice issued by the Great Britain Medicines & Healthcare Products Regulatory Agency in July 2008 with regard to the risk of suicidal thoughts and behaviour in association with varenicline. The agency reveals that depression or depressed mood and suicidal ideation are...

  • Prednisone.  // Reactions Weekly;9/5/2009, Issue 1268, p24 

    The article describes the case of a 20-year-old man who developed suicidal ideation while receiving treatment with prednisone for tuberculosis meningitis. Particular focus is given to his medical history, as well as his dosing regimen. He was admitted to the pyschiatric unit due to his acute...

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;2/9/2008, Issue 1188, p3 

    The article reports on the alert issued by New Zealand's Medsafe to healthcare professionals about an increased risk of suicidal thoughts and behaviours in antiepileptic drug recipients. Medsafe issued the alert after an analysis by the U.S. Food and Drug Administration (FDA) which revealed that...

  • Levofloxacin.  // Reactions Weekly;3/13/2010, Issue 1292, p24 

    The article describes the case of a 75-year-old man who thought of suicide while undergoing treatment with levofloxacin.

  • Levetiracetam.  // Reactions Weekly;1/10/2009, Issue 1234, p25 

    The article describes the case of two patients, a 30-year-old man and a 37-year-old woman, who developed suicidal ideation during treatment with levetiracetam for epilepsy. Information on the dosage and duration of levetiracetam therapy is provided. Time to reaction onset and patients outcomes...

  • Atomoxetine.  // Reactions Weekly;Jun2014, Vol. 1506 Issue 1, p7 

    The article focuses on a report received by the Centre for Adverse Reactions Monitoring (CARM) in New Zealand regarding suicidal ideation in a patient while receiving a treatment with atomoxetine.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics